A Phase 1 study of intravenous infusions of tigecycline in patients with acute myeloid leukemia

Efficacy of Tigecycline for Secondary Acinetobacter Bacteremia and Factors Associated with Treatment Failure

(2015) Bo-Huang Liou et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

AML cells have low spare reserve capacity in their respiratory chain that renders them susceptible to oxidative metabolic stress

(2015) S. Sriskanthadevan et al.   BLOOD

A Novel Formulation of Tigecycline Has Enhanced Stability and Sustained Antibacterial and Antileukemic Activity

(2014) Yulia Jitkova et al.   PLoS One

BCL-2 Inhibition Targets Oxidative Phosphorylation and Selectively Eradicates Quiescent Human Leukemia Stem Cells

(2013) Eleni D. Lagadinou et al.   Cell Stem Cell

Tigecycline: an update

(2013) Gary E. Stein et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Therapeutic potential of mitochondrial translation inhibition for treatment of acute myeloid leukemia

(2012) Aaron D Schimmer et al.   Expert Review of Hematology

Inhibition of Mitochondrial Translation as a Therapeutic Strategy for Human Acute Myeloid Leukemia

(2011) Marko Škrtić et al.   CANCER CELL

Tigecycline Pharmacokinetics in Subjects With Various Degrees of Renal Function

(2011) Joan M. Korth-Bradley et al.   JOURNAL OF CLINICAL PHARMACOLOGY

Dysregulation of the mevalonate pathway promotes transformation

(2010) J. W. Clendening et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Pharmacologic inhibition of fatty acid oxidation sensitizes human leukemia cells to apoptosis induction

(2009) Ismael Samudio et al.   JOURNAL OF CLINICAL INVESTIGATION

A Novel Mitochondrial DNA Mutation inCOX1Leads to Strokes, Seizures, and Lactic Acidosis

(2009) E. W. Y. Tam et al.   NEUROPEDIATRICS